Showing results (1391-1400 of 2,182) with videos related to

Sort By:
Pageof 219
The Journal of Gene Medicine|May 10, 2005
Assessment of optimal transduction of primary human skin keratinocytes by viral vectorsLaurent Gagnoux-Palacios, Catherine Hervouet, Flavia Spirito, et al.
The Journal of Gene Medicine|May 21, 2005
Upscaling of lentiviral vector production by tangential flow filtrationMartine Geraerts, Martine Michiels, Veerle Baekelandt, et al.
The Journal of Gene Medicine|July 19, 2005
Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale productionR Koldej, P Cmielewski, A Stocker, et al.
The Journal of Gene Medicine|July 19, 2005
Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomesShiroh Futaki, Yumi Masui, Ikuhiko Nakase, et al.
The Journal of Gene Medicine|July 26, 2005
Use of lipoplex-induced nuclear factor-kappaB activation to enhance transgene expression by lipoplex in mouse lungTakeshi Kuramoto, Makiya Nishikawa, Oranuch Thanaketpaisarn, et al.
The Journal of Gene Medicine|July 7, 2005
Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheterDavid R Koehler, Helena Frndova, Kitty Leung, et al.
The Journal of Gene Medicine|May 2, 2007
Comparison of cDNA and genomic forms of tyrosine hydroxylase gene therapy of the brain with Trojan horse liposomesChun-Fang Xia, Chun Chu, Jianyi Li, et al.
The Journal of Gene Medicine|May 2, 2007
In vivo expression of human ATP:cob(I)alamin adenosyltransferase (ATR) using recombinant adeno-associated virus (rAAV) serotypes 2 and 8Kirsten E Erger, Thomas J Conlon, Nicole A Leal, et al.
The Journal of Gene Medicine|May 19, 2007
G-CSF-lentivirus administration in rats provided sustained elevated neutrophil counts and subsequent EPO-lentivirus administration increased hematocritsMargaret Brzezinski, Ofer Yanay, Lanaya Waldron, et al.
The Journal of Gene Medicine|May 22, 2007
Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trialT H Brill, H R Kübler, H von Randenborgh, et al.
Pageof 219